Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7401)
All Articles published online
|
Publishing Process of This Article
|
Aug 7, 2013 (publication date) through May 20, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Song DS, Bae SH, Song MJ, Lee SW, Kim HY, Lee YJ, Oh JS, Chun HJ, Lee HG, Choi JY, Yoon SK. Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol 2013; 19(29): 4679-4688 [PMID: 23922465 DOI: 10.3748/wjg.v19.i29.4679] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i29/4679.htm |
| Number | Citing Articles |
| 1 |
Morihiko Ishizaki, Masaki Kaibori, Kosuke Matsui, Hiroki Ikeda, Katsunori Yoshida, Kazuichi Okazaki, Syuji Kariya, Noboru Tanigawa, Richi Nakatake, Hideyuki Matsushima, Tatsuma Sakaguchi, Masanori Kon. Phase I Study of Sorafenib in Combination with Intermittent Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma. Cancer Investigation 2017; 35(4): 271 doi: 10.1080/07357907.2017.1289382
|
| 2 |
T. Hamada, K. Yano, T. Wada, N. Imamura, M. Hiyoshi, K. Kondo, Atsushi Nanashima. Increased Survival Benefit of Adjuvant Intra‐arterial Infusion Chemotherapy in HCC Patients with Portal Vein Infiltration after Hepatectomy. World Journal of Surgery 2020; 44(8): 2770 doi: 10.1007/s00268-020-05527-w
|
| 3 |
Xing Lv, Peng-Bo Zhang, Er-lei Zhang, S. Yang. Predictive factors and prognostic models for Hepatic arterial infusion chemotherapy in Hepatocellular carcinoma: a comprehensive review. World Journal of Surgical Oncology 2025; 23(1) doi: 10.1186/s12957-025-03765-7
|
| 4 |
Sang Yi Moon, Sang Young Han, Yang-Hyun Baek. Efficacy of Hepatic Arterial Infusion Chemotherapy and Radiofrequency Ablation against Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization and Vascular Variation: A Case Study. Kosin Medical Journal 2021; 36(2): 161 doi: 10.7180/kmj.2021.36.2.161
|
| 5 |
Cisplatin/epirubicin/fluorouracil. Reactions Weekly 2021; 1853(1): 137 doi: 10.1007/s40278-021-95003-x
|
| 6 |
Siqi Zhao, Wubin Zheng, Chao Yu, Gaoxin Xu, Xinyi Zhang, Chao Pan, Yongheng Feng, Kunxing Yang, Jin Zhou, Yong Ma. The Role of Ferroptosis in the Treatment and Drug Resistance of Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.845232
|
| 7 |
Beom-Hui Lee, Dong-Shik Lee, Chan Woo Cho, Sung-Su Yun. Role and limitation of neoadjuvant hepatic arterial infusion chemotherapy in advanced hepatocelluar carcinoma patients with Child-Pugh class A. World Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1685-6
|
| 8 |
Do Seon Song, Myeong Jun Song, Si Hyun Bae, Woo Jin Chung, Jae Young Jang, Young Seok Kim, Sae Hwan Lee, Jun Yong Park, Hyung Joon Yim, Sung Bum Cho, Soo Young Park, Jin Mo Yang. A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Journal of Gastroenterology 2015; 50(4): 445 doi: 10.1007/s00535-014-0978-3
|
| 9 |
Wei-Lun Tsai, Kwok-Hung Lai, Huei-Lung Liang, Ping-I Hsu, Hoi-Hung Chan, Wen-Chi Chen, Hsien-Chung Yu, Feng-Woei Tsay, Huay-Min Wang, Hung-Chih Tsai, Jin-Shiung Cheng, Erica Villa. Hepatic Arterial Infusion Chemotherapy for Patients with Huge Unresectable Hepatocellular Carcinoma. PLoS ONE 2014; 9(5): e92784 doi: 10.1371/journal.pone.0092784
|
| 10 |
Zhu-Jian Deng, Le Li, Yu-Xian Teng, Yu-Qi Zhang, Yu-Xin Zhang, Hao-Tian Liu, Jian-Li Huang, Zhen-Xiu Liu, Liang Ma, Jian-Hong Zhong. Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy. Journal of Clinical and Translational Hepatology 2022; 10(1): 147 doi: 10.14218/JCTH.2021.00179
|
| 11 |
Hee Chul Nam, Pil Soo Sung, Ho Jong Chun, Dong Goo Kim, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon. Liver Transplantation after Successful Downstaging with Hepatic Arterial Infusion Chemotherapy in a Patient with Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Journal of Liver Cancer 2019; 19(1): 64 doi: 10.17998/jlc.19.1.64
|
| 12 |
Ming-Feng Li, Huei-Lung Liang, Chia-Ling Chiang, Wei-Lun Tsai, Wen-Chi Chen, Cheng-Chung Tsai, I-Shu Chen. New Regimen of Combining Hepatic Arterial Infusion Chemotherapy and Lipiodol Embolization in Treating Hepatocellular Carcinoma with Main Portal Vein Invasion. Journal of Personalized Medicine 2022; 13(1): 88 doi: 10.3390/jpm13010088
|
| 13 |
Young Eun Ahn, Sang Jun Suh, Hyung Joon Yim, Yeon Seok Seo, Eileen L. Yoon, Tae Hyung Kim, Young Sun Lee, Sun Young Yim, Hae Rim Kim, Seong Hee Kang, Young Kul Jung, Ji Hoon Kim, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun. Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Gut and Liver 2021; 15(2): 284 doi: 10.5009/gnl19367
|
| 14 |
Hong Tao Hu, Jun Peng Luo, Hai-Liang Li, Chen Yang Guo, Quan Jun Yao, Xiang Geng, Li Jiang. Transarterial chemoembolization combined with computed tomography-guided 125iodine implantation enhances survival in hepatocellular carcinoma patients with portal vein tumor thrombus. Oncotarget 2017; 8(17): 29258 doi: 10.18632/oncotarget.16491
|
| 15 |
Wei Zhang, Deliang Ouyang, Zhangkan Huang, Xu Che. Hepatic arterial infusion chemotherapy versus sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombus: An updated meta-analysis and systematic review. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1085166
|
| 16 |
Chae-June Lim, Ji-Yun Hong, Yang-Seok Ko, Min-Woo Chung, Chung-Hwan Jun, Sung-Kyu Choi, Sung-Bum Cho. High-dose versus Low-dose 5-Fluorouracil and Cisplatin Based Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma. Journal of Liver Cancer 2019; 19(1): 38 doi: 10.17998/jlc.19.1.38
|
| 17 |
Ninggang Zheng, Xiaodong Wei, Dongzhi Zhang, Wenxiao Chai, Ming Che, Jiangye Wang, Binbin Du. Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus. Medicine 2016; 95(26): e3959 doi: 10.1097/MD.0000000000003959
|
| 18 |
Su Ho Kim, Ho Jong Chun, Youdong Kim, Jung Suk Oh, Byung Gil Choi, Hae Giu Lee. Impact of aortoceliac angle in implantation of subcutaneous hepatic artery port-catheter system for hepatic arterial infusion chemotherapy via femoral approach. Acta Radiologica 2023; 64(9): 2667 doi: 10.1177/02841851231181321
|
| 19 |
Yuta Kimura, Yukio Tokumitsu, Yoshitaro Shindo, Hiroto Matsui, Satoshi Matsukuma, Issei Saeki, Taro Takami, Takahiro Yamasaki, Tatsuya Ioka, Hiroaki Nagano. Induction hepatic arterial infusion chemotherapy followed by surgery for hepatocellular carcinoma with massive portal vein tumor thrombosis: a case series of 20 patients. Journal of Medical Case Reports 2025; 19(1) doi: 10.1186/s13256-025-05253-8
|
| 20 |
Takahiro Yamasaki, Issei Saeki, Isao Sakaida. Efficacy of iron chelator deferoxamine for hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma patients refractory to current treatments. Hepatology International 2014; 8(S2): 492 doi: 10.1007/s12072-013-9515-3
|
| 21 |
Xinyu Chen, Lin Lai, Jiazhou Ye, Lequn Li. Downstaging Therapies for Unresectable Hepatocellular Carcinoma Prior to Hepatic Resection: A Systematic Review and Meta-Analysis. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.740762
|
| 22 |
Hong-Tao Hu, Jun-Peng Luo, Guang-Shao Cao, Zhen Li, Ming Jiang, Chen-Yang Guo, Hang Yuan, Quan-Jun Yao, Xiang Geng, Jung-Hoon Park, Hong-Tao Cheng, Li Jiang, Jun-Li Ma, Yan Zhao, Hai-Liang Li. Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Treated With Transarterial Chemoembolization and Sorafenib vs.125Iodine Implantation. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.806907
|
| 23 |
Su Ho Kim, Jung Suk Oh, Ho Jong Chun, Byung Gil Choi, Hae Giu Lee. Dual-Port versus Mono-Port Implantation for Intra-Arterial Chemoinfusion Therapy for Treatment of Hepatocellular Carcinoma in Patients with Anatomic Hepatic Artery Variation. Journal of Vascular and Interventional Radiology 2019; 30(1): 23 doi: 10.1016/j.jvir.2018.06.006
|
| 24 |
Kuan-Ting Chen, Kun-Feng Tsai, Henry W. C. Leung, Agnes L. F. Chan, Shyh-Yau Wang, Huei-Lung Liang, Sheng-Yeh Tang, Chu-Kuang Chou, Hsin-Yu Chen, Shan-Ho Chan, Ming-Feng Li. Hepatic Arterial Infusion Chemotherapy Followed by Lipiodol Infusion for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Single-Center Experience. Medicina 2021; 57(8): 779 doi: 10.3390/medicina57080779
|
| 25 |
Masahito Nakano, Takashi Niizeki, Hiroaki Nagamatsu, Masatoshi Tanaka, Ryoko Kuromatsu, Manabu Satani, Shusuke Okamura, Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, Yu Noda, Hironori Koga, Takuji Torimura. Clinical effects and safety of intra‑arterial infusion therapy of cisplatin suspension in lipiodol combined with 5‑fluorouracil versus sorafenib, for advanced hepatocellular carcinoma with macroscopic vascular invasion without extra‑hepatic spread: A prospective cohort study. Molecular and Clinical Oncology 2017; doi: 10.3892/mco.2017.1442
|
| 26 |
Rinpei Imamine, Toshiya Shibata, Ken Shinozuka, Kaori Togashi. Complications in hepatic arterial infusion chemotherapy: retrospective comparison of catheter tip placement in the right/left hepatic artery vs. the gastroduodenal artery. Surgery Today 2017; 47(7): 851 doi: 10.1007/s00595-016-1465-7
|
| 27 |
Woo Kyun Bae, Byung Chan Lee, Hyeon-Jong Kim, Je-Jung Lee, Ik-Joo Chung, Sung Bum Cho, Yang Seok Koh. A Phase I Study of Locoregional High-Dose Autologous Natural Killer Cell Therapy With Hepatic Arterial Infusion Chemotherapy in Patients With Locally Advanced Hepatocellular Carcinoma. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.879452
|
| 28 |
Khadijah M. Alzaydi, Tamer S. Saleh. 2-Aryl hydrazonopropanal pharmacophores as potent cytotoxic agents against human hepatocellular carcinoma cell line. Medicinal Chemistry Research 2020; 29(2): 199 doi: 10.1007/s00044-019-02473-8
|
| 29 |
Chia-Ling Chiang, Huei-Lung Liang, Kuo-Chen Chang, Wei-Lun Tsai, Hsien-Chung Yu, Kung-Hung Lin, Ming-Feng Li. Advanced hepatocellular carcinoma with major portal vein invasion: Therapeutic outcomes of hepatic arterial infusion chemotherapy vs concurrent radiotherapy. Journal of the Chinese Medical Association 2024; 87(2): 171 doi: 10.1097/JCMA.0000000000001040
|
| 30 |
Kichang Han, Jin Hyoung Kim, Gi-Young Ko, Dong Il Gwon, Kyu-Bo Sung. Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive review. World Journal of Gastroenterology 2016; 22(1): 407-416 doi: 10.3748/wjg.v22.i1.407
|
| 31 |
Yunyan Ling, Meng Jin, Meiyan Zhu, Yan Wang, Yong Chen, Zhenwei Peng. Efficacy of Different Treatments for Patients with Advanced Hepatocellular Carcinoma: A System Review and Network Meta-Analysis. International Journal of Surgery Oncology 2022; 7(1): 58 doi: 10.29337/ijsonco.140
|